(Q41012776)

25 September 2017

title

Decreased drug accumulation and increased tolerance to DNA damage in tumor cells with a low level of cisplatin resistance (English)

1 reference

25 September 2017

0 references

1

1 reference

25 September 2017

2

1 reference

25 September 2017

8

1 reference

25 September 2017

11

1 reference

25 September 2017

Supino R

3

1 reference

25 September 2017

Romanelli S

4

1 reference

25 September 2017

Pensa T

5

1 reference

25 September 2017

Carenini N

6

1 reference

25 September 2017

Viano I

7

1 reference

25 September 2017

Leone R

9

1 reference

25 September 2017

Apostoli P

10

1 reference

25 September 2017

Gambetta RA

12

1 reference

25 September 2017

Zunino F

13

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 April 1998

1 reference

25 September 2017

published in

Biochemical Pharmacology

1 reference

25 September 2017

volume

55

1 reference

25 September 2017

issue

8

1 reference

25 September 2017

page(s)

1247-1254

1 reference

Drugs five years later. Cisplatin

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900599-6

Cellular accumulation of the anticancer agent cisplatin: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900599-6

Short-term cis-diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900599-6

The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900599-6

Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum(II).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900599-6

Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900599-6

7 January 2021

Tissue sulfhydryl groups

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900599-6

A sensitive method to measure physical and chemical carcinogen-induced “unscheduled DNA synthesis” in rapidly dividing eukaryotic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900599-6

Signaling and drug sensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900599-6

DNA repair: enzymatic mechanisms and relevance to drug response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900599-6

Reduced drug accumulation as a major mechanism of acquired resistance to cisplatin in a human ovarian carcinoma cell line: circumvention studies using novel platinum (II) and (IV) ammine/amine complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900599-6

Effects of cisplatin on cell cycle kinetics, morphological change, and cleavage pattern of DNA in two human ovarian carcinoma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900599-6

Differential formation and enhanced removal of specific cisplatin-DNA adducts in two cisplatin-selected resistant human testicular teratoma sublines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900599-6

10.1016/S0006-2952(97)00599-6

7 January 2021

Identifiers

DOI

1 reference

25 September 2017

1 reference